Beacon-Based Remote Measurement of Social Behavior in ASD Clinical Trials: A Technical Feasibility Assessment

被引:2
|
作者
Kriara, Lito [1 ]
Hipp, Joerg [2 ]
Chatham, Christopher [2 ]
Nobbs, David [1 ]
Slater, David [1 ]
Lipsmeier, Florian [1 ]
Lindemann, Michael [1 ]
机构
[1] Roche Innovat Ctr Basel, Digital Biomarkers, Roche Pharma Res & Early Dev pRED, CH-4070 Basel, Switzerland
[2] Roche Innovat Ctr Basel, Roche pRED, Neurosci & Rare Dis, CH-4070 Basel, Switzerland
关键词
autism spectrum disorder; Bluetooth low energy; clinical trials; digital biomarker; digital health technology tool; remote patient monitoring; sensor-based measure; sociability;
D O I
10.3390/s21144664
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
In this work, we propose a Bluetooth low energy (BLE) beacon-based algorithm to enable remote measurement of the social behavior of the participants of an observational Autism Spectrum Disorder (ASD) clinical trial (NCT03611075). We have developed a mobile application for a smartphone and a smartwatch to collect beacon signals from BLE beacon sensors as well as to store information about the participants' household rooms. Our goal is to collect beacon information about the time the participants spent in different rooms of their household to infer sociability information. We applied the same technology and setup in an internal experiment with healthy volunteers to evaluate the accuracy of the proposed algorithm in 10 different home setups, and we observed an average accuracy of 97.2%. Moreover, we show that it is feasible for the clinical study participants/caregivers to set up the BLE beacon sensors in their homes without any technical help, with 96% of them setting up the technology on the first day of data collection. Next, we present results from one-week location data from study participants collected through the proposed technology. Finally, we provide a list of good practice guidelines for optimally applying beacon technology for indoor location monitoring. The proposed algorithm enables us to estimate time spent in different rooms of a household that can pave the development of objective sociability features and eventually support decisions regarding drug efficacy in ASD.
引用
收藏
页数:17
相关论文
共 6 条
  • [1] Clinical assessment of ASD in adults using self- and other-report: Psychometric properties and validity of the Adult Social Behavior Questionnaire (ASBQ)
    Horwitz, E. H.
    Schoevers, R. A.
    Ketelaars, C. E. J.
    Kan, C. C.
    van Lammeren, A. M. D. N.
    Meesters, Y.
    Spek, A. A.
    Wouters, S.
    Teunisse, J. P.
    Cuppen, L.
    Bartels, A. A. J.
    Schuringa, E.
    Moorlag, H.
    Raven, D.
    Wiersma, D.
    Minderaa, R. B.
    Hartman, C. A.
    RESEARCH IN AUTISM SPECTRUM DISORDERS, 2016, 24 : 17 - 28
  • [2] Patient and Healthcare Professional Insights of Home- and Remote-Based Clinical Assessment: A Qualitative Study from Spain and Brazil to Determine Implications for Clinical Trials and Current Practice
    Lalanza, Simon
    Pena, Catalina
    Bezos, Carlos
    Yamauchi, Nancy
    Taffner, Viviane
    Rodrigues, Kelly
    Manrique, Marta Garcia
    Jareno, Ana Rubio
    Gil, Andreia Lemos
    ADVANCES IN THERAPY, 2023, 40 (04) : 1670 - 1685
  • [3] Patient and Healthcare Professional Insights of Home- and Remote-Based Clinical Assessment: A Qualitative Study from Spain and Brazil to Determine Implications for Clinical Trials and Current Practice
    Simón Lalanza
    Catalina Peña
    Carlos Bezos
    Nancy Yamauchi
    Viviane Taffner
    Kelly Rodrigues
    Marta Garcia Manrique
    Ana Rubio Jareño
    Andreia Lemos Gil
    Advances in Therapy, 2023, 40 (4) : 1670 - 1685
  • [4] The quality of measurement properties of neurocognitive assessment in brain tumor clinical trials over the last 30 years: a COSMIN checklist-based approach
    De Martino, Maria
    Santini, Barbara
    Cappelletti, Giovanna
    Mazzotta, Annapina
    Rasi, Matteo
    Bulgarelli, Giorgia
    Annicchiarico, Luciano
    Marcocci, Alessandro
    Talacchi, Andrea
    NEUROLOGICAL SCIENCES, 2020, 41 (11) : 3105 - 3121
  • [5] The quality of measurement properties of neurocognitive assessment in brain tumor clinical trials over the last 30 years: a COSMIN checklist-based approach
    Maria De Martino
    Barbara Santini
    Giovanna Cappelletti
    Annapina Mazzotta
    Matteo Rasi
    Giorgia Bulgarelli
    Luciano Annicchiarico
    Alessandro Marcocci
    Andrea Talacchi
    Neurological Sciences, 2020, 41 : 3105 - 3121
  • [6] Comparison of Predicted vs. Actual Enrollment Into the NIH StrokeNet DEFUSE 3 Trial: Effectiveness of a Population-Based Epidemiology Feasibility Assessment in Improving Enrollment Into Clinical Trials.
    Kleindorfer, Dawn O.
    Moomaw, Charles J.
    Mlynash, Michael
    Broderick, Joseph P.
    Khatri, Pooja
    Saver, Jeffrey L.
    Alwell, Kathleen
    Kemp, Stephanie
    Janis, Scott
    Moy, Claudia
    Woo, Daniel
    Flaherty, Matthew L.
    Ferioli, Simona
    Adeoye, Opeolu
    Kissela, Brett M.
    Lansberg, Maarten
    Albers, Greg
    STROKE, 2019, 50